Opendata, web and dolomites

PATH-TOX SIGNED

Artificial Intelligence to transform Drug and Chemical safety testing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PATH-TOX project word cloud

Explore the words cloud of the PATH-TOX project. It provides you a very rough idea of what is the project "PATH-TOX" about.

benchmarking    accelerate    thousands    purpose    toxicity    global    swiss    pharmaceuticals    perform    competition    sme    compare    data    undergo    components    ltd    validation    artificial    animal    diagnostic    pharma    tests    janssen    deciphex    risky    pathologists    intelligence    tissues    consuming    manually    regards    review    yields    aided    lack    framework    image    toxicology    workflow    pathological    tools    expensive    routinely    ai    engine    customers    animals    cros    abnormal    performance    competitors    markets    reducing    drugs    tox    trained    drug    hence    big    date    worldwide    sections    mainly    optimise    pathologist    belgium    cloud    veterinary    normal    individual    discovery    streamline    patholytix    looming    knock    irish    effect    prototype    expand    direct    tissue    once    upfront    led    time    automatically    fit    pathology    solutions    interface    liver    market    manual    computer    safety    crisis   

Project "PATH-TOX" data sheet

The following table provides information about the project.

Coordinator
JANSSEN PHARMACEUTICA NV 

Organization address
address: TURNHOUTSEWEG 30
city: BEERSE
postcode: 2340
website: www.janssenpharmaceutica.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 2˙935˙000 €
 EC max contribution 2˙054˙499 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JANSSEN PHARMACEUTICA NV BE (BEERSE) coordinator 134˙531.00
2    DECIPHEX LIMITED IE (MORNINGTON MEATH) participant 1˙626˙843.00
3    PDS PATHOLOGY DATA SYSTEMS AG CH (PRATTEIN) participant 293˙125.00

Map

 Project objective

Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which yields thousands of tissue sections that currently must be assessed manually by a trained veterinary pathology. However, there is a looming crisis due to the lack pathologists.

The PATH-TOX consortium is led by Irish SME, Deciphex Ltd, and includes key partners such as Janssen Pharmaceuticals in Belgium and Pathology Data Systems Ltd a Swiss based SME. They are creating PATHOLYTIX-TOX a computer aided diagnostic system to streamline the pathology review process. Using state-of-the-art artificial intelligence (AI) image analysis tools it will automatically identify the normal and abnormal tissues upfront, allowing the pathologist to focus mainly on the abnormal cases, hence accelerate workflow.

To date, we have built a working prototype of the image analysis engine, which can identify abnormal tissue in liver. In this project we will optimise the engine further to improve performance and expand its use into other tissues. We will also develop other features such as the user interface, data management and cloud framework. Once developed, we will perform a comprehensive validation and benchmarking study to compare to manual pathology assessment.

There is a large, growing, global target market for PATHOLYTIX-TOX. Pharma and CROs worldwide routinely perform thousands of animal toxicology tests each year, who are potential customers. With regards to competitors, there is no direct competition. Competitors offer individual components of the pathological workflow, not fit-for-purpose solutions for the toxicology pathology market.

Overall, PATHOLYTIX would have a big impact on drug development, by reducing the time required for pathology review and associated costs. This should have a knock on effect for the global and EU markets, reducing time and cost for new drugs to get to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PATH-TOX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PATH-TOX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

De-RISC (2019)

De-RISC: Dependable Real-time Infrastructure for Safety-critical Computer

Read More  

SAFE-CAB (2019)

Laser-Assisted Surgical System to Revolutionize Cardiac Bypass Surgeries

Read More